ProCE Banner Activity

Managing Advanced or Recurrent Endometrial Cancer With Immune Checkpoint Inhibitors

Clinical Thought
Read my thoughts to learn how the management of endometrial cancer continues to evolve with the use of immunotherapies as single agents or in combinations.

Released: June 28, 2021

Expiration: June 27, 2022

No longer available for credit.

Share

Faculty

Maria-Pilar Barretina-Ginesta

Maria-Pilar Barretina-Ginesta, MD

Associate Professor
Medical Sciences Department
Girona University
Assistant Chief
Medical Oncology Department
Institut Catala D Oncologia
Girona, Spain

Supporters

Supported by an educational grant from

GlaxoSmithKline